Role of the stem domain of matriptase in the interaction with its physiological inhibitor, hepatocyte growth factor activator inhibitor type I

Journal of Biochemistry

Volumn 145, Issue 6, 2009, Pages 783-790

  Kojima, Kenji ^a   Tsuzuki, Satoshi ^a   Fushiki, Tohru ^a   Inouye, Kuniyo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Hepatocyte growth factor activator inhibitor type I; Inhibitory interaction; Matriptase; Membrane type serine protease; Stem domain

Indexed keywords

ACETYLLYSYLTHREONYLLYSYLGLUTAMYLLEUCYLARGINYLPEPTIDYL 4 METHYL COUMARYL 7 AMIDE; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 1; MATRIPTASE; PEPTIDYL 4 METHYLCOUMARYL 7 AMIDE; POLYPEPTIDE; SERINE PROTEINASE INHIBITOR; TERT BUTYLOXYCARBONYL [2 AMINO 3 (BENZYLOXYCARBONYL)PROPIONYL]PROLYLARGINYLPEPTIDYL 4 METHYL COUMARYL 7 AMIDE; TERT BUTYLOXYCARBONYLGLUTAMYLALANYLARGINYLPEPTIDYL 4 METHYL COUMARYL 7 AMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME STRUCTURE; HYDROLYSIS; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION;

ANIMALS; BLOTTING, WESTERN; CHO CELLS; COUMARINS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; MEMBRANE GLYCOPROTEINS; MODELS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SERINE ENDOPEPTIDASES;

EID: 67651146418     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvp036     Document Type: Article

References (25)

1. Lin, C.Y., Tseng, I.C., Chou, F.P., Su, S.F., Chen, Y.W., Johnson, M.D., and Dickson, R.B. (2008) Zymogen activation, inhibition, and ectodomain shedding of matriptase. Front. Biosci. 13, 621-635
2. Darragh, M.R., Bhatt, A.S., and Craik, C.S. (2008) MT-SP1 proteolysis and regulation of cell-microenvironment interactions. Front. Biosci. 13, 528-539
3. Bugge, T.H., List, K., and Szabo, R. (2007) Matriptasedependent cell surface proteolysis in epithelial development and pathogenesis. Front. Biosci. 12, 5060-5070
4. Kim, M.G., Chen, C., Lyu, M.S., Cho, E.G., Park, D., Kozak, C., and Schwartz, R.H. (1999) Cloning and chromosomal mapping of a gene isolated from thymic stromal cells encoding a new mouse type II membrane serine protease, epithin, containing four LDL receptor modules and two CUB domains. Immunogenetics 49, 420-428 (Pubitemid 29178825)
5. Zhang, T., Cai, X, Schlegelberger, B., and Zheng, S. (1998) Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24->q25 by in situ hybridization. Cytogenet. Cell Genet. 83, 56-57
6. Takeuchi, T., Shuman, M.A., and Craik, C.S. (1999) Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane- type serine protease in epithelial cancer and normal tissue. Proc. Natl Acad. Sci. USA 96, 11054-11061
7. Oberst, M.D., Williams, C.A., Dickson, R.B., Johnson, M.D., and Lin, C.Y. (2003) The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem. 278, 26773-26779
8. Takeuchi, T., Harris, J.L., Huang, W., Yan, K.W., Coughlin, S.R., and Craik, C.S. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinasetype plasminogen activator as substrates. J. Biol. Chem. 275, 26333-26342
9. Lee, S.L., Dickson, R.B., and Lin, C.Y. (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275, 36720-36725
10. Satomi, S., Yamasaki, Y., Tsuzuki, S., Hitomi, Y., Iwanaga, T., and Fushiki, T. (2001) A role for membranetype serine protease (MT-SP1) in intestinal epithelial turnover. Biochem. Biophys. Res. Commun. 287, 995-1002
11. Kojima, K., Tsuzuki, S., Fushiki, T., and Inouye, K. (2009) The activity of a type II transmembrane serine protease, matriptase, is dependent solely on the catalytic domain. Biosci. Biotechnol. Biochem. 73, 454-456
12. Kirchhofer, D., Peek, M., Li, W., Stamos, J., Eigenbrot, C., Kadkhodayan, S., Elliott, J.M., Corpuz, R.T., Lazarus, R.A., and Moran, P. (2003) Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J. Biol. Chem. 278, 36341-36349
13. Netzel-Armett, S., Currie, B.M., Szabo, R., Lin, C.Y., Chen, L.M., Chai, K.X., Antalis, T.M., Bugge, T.H., and List, K. (2006) Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J. Biol. Chem. 281, 32941-32945
14. Oberst, M.D., Singh, B., Ozdemirli, M., Dickson, R.B., Johnson, M.D., and Lin, C. Y. (2003) Characterization of matriptase expression in normal human tissues. J. Histochem. Cytochem. 51, 1017-1025
15. Szabo, R. and Bugge, T.H. (2008) Type II transmembrane serine proteases in development and disease. Int. J. Biochem. Cell Biol. 40, 1297-1316
16. Qiu, D., Owen, K., Gray, Bass, R., and Ellis, V. (2007) Roles and regulation of membrane-associated serine proteases. Biochem. Soc. Trans. 35, 582-1587
17. Lu, D., Yuan, X., Zheng, X., and Sadler, J.E. (1997) Bovine proenteropeptidase is activated by trypsin, and the specificity of enteropeptidase depends on the heavy chain. J. Biol. Chem. 272, 31293-31300
18. Mikhailova, A.G. and Rumsh, L.D. (1999) Autolysis of bovine enteropeptidase heavy chain: evidence of fragment 118-465 involvement in trypsinogen activation. FEBS Lett. 442, 226-230
19. Shimomura, T., Denda, K., Kitamura, A., Kawaguchi, T., Kito, M., Kondo, J., Kagaya, S., Qin, L., Takata, H., Miyazawa, K., and Kitamura, N. (1997) Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272, 6370-6376
20. Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y., and Kitamura, N. (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor toblood coagulation factor XII. J. Biol. Chem. 268, 10024-10028
21. Shimomura, T., Denda, K., Kawaguchi, T., Matsumoto, K., Miyazawa, K., and Kitamura, N. (1999) Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J. Biochem. (Tokyo) 126, 821-828
22. Tsuzuki, S., Murai, N., Miyake, Y., Inouye, K., Hirayasu, H., Iwanaga, T., and Fushiki, T. (2005) Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes. Biochem. J. 388, 679-687 (Pubitemid 40839945)
23. Kojima, K., Tsuzuki, S., Fushiki, T., and Inouye, K (2008) Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase. J. Biol. Chem. 283, 2478-2487
24. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
25. Szabo, R., Hobson, J.P., List, K., Molinolo, A., Lin, C.Y., and Bugge, T.H. (2008) Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J. Biol. Chem. 283, 29495-29504